Development of an artificial intelligence system to improve cancer clinical trial eligibility screening

This study suggests that artificial intelligence could yield sizable improvements over standard practices in several aspects of the patient screening process, as well as in approaches to feasibility, site selection, and trial selection.PMID:38503584 | DOI:10.1016/j.bulcan.2024.01.010

Source: Bulletin du Cancer - March 19, 2024 Category: Cancer & Oncology Authors: Maud G édor Emmanuel Desandes M élanie Chesnel Jean-Louis Merlin Fr édéric Marchal Aur élien Lambert Arnaud Baudin Source Type: research